CN Patent
CN103739647B — 用于治疗疾病的NF‑κB的非激素甾体调节剂
Assigned to Lei Wogen Biological Medicine Co Ltd · Expires 2017-06-09 · 9y expired
What this patent protects
本发明涉及用于治疗疾病的NF‑κB的非激素甾体调节剂。所述化合物可用于制备用于减轻外伤性脑损伤、脊髓损伤等疾病的症状的药物。
USPTO Abstract
本发明涉及用于治疗疾病的NF‑κB的非激素甾体调节剂。所述化合物可用于制备用于减轻外伤性脑损伤、脊髓损伤等疾病的症状的药物。
Drugs covered by this patent
- Agamree (VAMOROLONE) · Catalyst Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.